Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria

Summary

Adherence of infected erythrocytes to vascular endothelium causes acute endothelial cell (EC) activation during Plasmodium falciparum infection. Consequently, proteins stored in Weibel-Palade (WP) bodies within EC are secreted into the plasma. Osteoprotegerin (OPG) binds to VWF and consequently is stored within WP bodies. Given the critical role of EC activation in the pathogenesis of severe malaria, we investigated plasma OPG levels in children with P. falciparum malaria. At presentation, plasma OPG levels were significantly elevated in children with cerebral malaria (CM) compared to healthy controls (means 16.0 vs 0.8 ng/ml; p<0.01). Importantly, OPG levels were also significantly higher in children with CM who had a fatal outcome, compared to children with CM who survived. Finally, in children with CM, plasma OPG levels correlated with other established prognostic indices (including plasma lactate levels and peripheral parasite density). To further investigate the relationship between severe malaria and OPG, we utilised a murine model of experimental CM in which C57BL/6J mice were infected with P. berghei ANKA. Interestingly, plasma OPG levels were increased 4.6 fold within 24 hours following P. berghei inoculation. This early marked elevation in OPG levels was observed before any objective clinical signs were apparent, and preceded the development of peripheral blood parasitaemia. As the mice became increasingly unwell, plasma OPG levels progressively increased. Collectively, these data suggest that OPG constitutes a novel biomarker with prognostic significance in patients with severe malaria. In addition, further studies are required to determine whether OPG plays a role in modulating malaria pathogenesis.

 

MissingLinkText

Keywords

Osteoprotegerin - von Willebrand factor - cerebral malaria - Plasmodium falciparum - Plasmodium berghei

 

 

MissingLinkText

Conflicts of interest

None declared.

^* These authors contributed equally to this study.

• References

• 1 Lopez AD, Mathers CD, Ezzati M. et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
• 2 Dondorp AM, Lee SJ, Faiz MA. et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis 2008; 47: 151-157.
• 3 Seydel KB, Kampondeni SD, Valim C. et al. Brain swelling and death in children with cerebral malaria. N Engl J Med 2015; 372: 1126-1137.
• 4 Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998; 79: 1-53.
• 5 Turner GD, Ly VC, Nguyen TH. et al. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Path-ol 1998; 152: 1477-1487.
• 6 Craig A, Scherf A. Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol Biochem Parasitol 2001; 115: 129-143.
• 7 Grau GE, Taylor TE, Molyneux ME. et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320: 1586-1591.
• 8 Lenting PJ, Christophe OD, Denis CV. von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood 2015; 125 (13) 2019-28
• 9 Nightingale T, Cutler D. The secretion of von Willebrand factor from endothe-lial cells; an increasingly complicated story. J Thromb Haemost 2013; 11 (Suppl. 01) 192-201.
• 10 Valentijn KM, Sadler JE, Valentijn JA. et al. Functional architecture of Weibel-Palade bodies. Blood 2011; 117: 5033-5043.
• 11 Conroy AL, Phiri H, Hawkes M. et al. Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One 2010; 5: e15291.
• 12 de Mast Q, Groot E, Asih PB. et al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am J Trop Med Hyg 2009; 80: 492-498.
• 13 Erdman LK, Dhabangi A, Musoke C. et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One 2011; 6: e17440.
• 14 Hollestelle MJ, Donkor C, Mantey EA. et al. von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. Br J Haematol 2006; 133: 562-569.
• 15 Larkin D, de Laat B, Jenkins PV. et al. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog 2009; 5: e1000349.
• 16 Lowenberg EC, Charunwatthana P, Cohen S. et al. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13. Thromb Haemost 2010; 103: 181-187.
• 17 Phiri HT, Bridges DJ, Glover SJ. et al. Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria. PLoS One 2011; 6: e25626.
• 18 de Mast Q, de Groot PG, van Heerde WL. et al. Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy. Br J Haematol 2010; 151: 495-503.
• 19 de Mast Q, Groot E, Lenting PJ. et al. Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. J Infect Dis 2007; 196: 622-628.
• 20 Bridges DJ, Bunn J, van Mourik JA. et al. Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood 2010; 115: 1472-1474.
• 21 Conroy AL, Lafferty EI, Lovegrove FE. et al. Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J 2009; 8: 295.
• 22 Lovegrove FE, Tangpukdee N, Opoka RO. et al. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One 2009; 4: e4912.
• 23 Yeo TW, Lampah DA, Gitawati R. et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci USA 2008; 105: 17097-17102.
• 24 Zannettino AC, Holding CA, Diamond P. et al. Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. J Cell Physiol 2005; 204: 714-723.
• 25 Shahbazi S, Lenting PJ, Fribourg C. et al. Characterization of the interaction between von Willebrand factor and osteoprotegerin. J Thromb Haemost 2007; 05: 1956-1962.
• 26 Lacey DL, Timms E, Tan HL. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-176.
• 27 Baud’huin M, Duplomb L, Teletchea S. et al. Osteoprotegerin: multiple partners for multiple functions. Cytokine Growth Factor Rev 2013; 24: 401-409.
• 28 Caidahl K, Ueland T, Aukrust P. Osteoprotegerin: a biomarker with many faces. Arterioscler Thromb Vasc Biol 2010; 30: 1684-1686.
• 29 Mangan SH, Van Campenhout A, Rush C. et al. Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2. Cardiovasc Res 2007; 76: 494-505.
• 30 Zauli G, Corallini F, Bossi F. et al. Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. Blood 2007; 110: 536-543.
• 31 Moxon CA, Chisala NV, Wassmer SC. et al. Persistent endothelial activation and inflammation after Plasmodium falciparum Infection in Malawian children. J Infect Dis 2014; 209: 610-615.
• 32 Moxon CA, Wassmer SC, Milner Jr. DA. et al. Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children. Blood 2013; 122: 842-851.
• 33 Baptista FG, Pamplona A, Pena AC. et al. Accumulation of Plasmodium ber-ghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun 2010; 78: 4033-4039.
• 34 de Souza JB, Riley EM. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 2002; 04: 291-300.
• 35 Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 05: 722-735.
• 36 Amante FH, Stanley AC, Randall LM. et al. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol 2007; 171: 548-559.
• 37 McGrath RT, McKinnon TA, Byrne B. et al. Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. Blood 2010; 115: 2666-2673.
• 38 Krishna S, Waller DW, ter Kuile F. et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg 1994; 88: 67-73.
• 39 Simonet WS, Lacey DL, Dunstan CR. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319.